Cargando…

Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development

SIMPLE SUMMARY: Cholangiocarcinoma is the second most frequent primary liver tumor in humans. In this review, we report current findings on the mechanisms linking well-known risk factors to this cancer. These pathways may be in part involved in risk factors unrelated to cholangiocarcinoma forms. ABS...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceci, Ludovica, Zhou, Tianhao, Lenci, Ilaria, Meadows, Vik, Kennedy, Lindsey, Li, Ping, Ekser, Burcin, Milana, Martina, Zhang, Wenjun, Wu, Chaodong, Sato, Keisaku, Chakraborty, Sanjukta, Glaser, Shannon S., Francis, Heather, Alpini, Gianfranco, Baiocchi, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945938/
https://www.ncbi.nlm.nih.gov/pubmed/35326593
http://dx.doi.org/10.3390/cancers14061442
_version_ 1784674073633095680
author Ceci, Ludovica
Zhou, Tianhao
Lenci, Ilaria
Meadows, Vik
Kennedy, Lindsey
Li, Ping
Ekser, Burcin
Milana, Martina
Zhang, Wenjun
Wu, Chaodong
Sato, Keisaku
Chakraborty, Sanjukta
Glaser, Shannon S.
Francis, Heather
Alpini, Gianfranco
Baiocchi, Leonardo
author_facet Ceci, Ludovica
Zhou, Tianhao
Lenci, Ilaria
Meadows, Vik
Kennedy, Lindsey
Li, Ping
Ekser, Burcin
Milana, Martina
Zhang, Wenjun
Wu, Chaodong
Sato, Keisaku
Chakraborty, Sanjukta
Glaser, Shannon S.
Francis, Heather
Alpini, Gianfranco
Baiocchi, Leonardo
author_sort Ceci, Ludovica
collection PubMed
description SIMPLE SUMMARY: Cholangiocarcinoma is the second most frequent primary liver tumor in humans. In this review, we report current findings on the mechanisms linking well-known risk factors to this cancer. These pathways may be in part involved in risk factors unrelated to cholangiocarcinoma forms. ABSTRACT: The poor prognosis of cholangiocarcinoma in humans is related to several factors, such as (i) the heterogeneity of the disease, (ii) the late onset of symptoms and (iii) the limited comprehension of the carcinogenic pathways determining neoplastic changes, which all limit the pursuit of appropriate treatment. Several risk factors have been recognized, including different infective, immune-mediated, and dysmorphogenic disorders of the biliary tree. In this review, we report the details of possible mechanisms that lead a specific premalignant pathological condition to become cholangiocarcinoma. For instance, during liver fluke infection, factors secreted from the worms may play a major role in pathogenesis. In primary sclerosing cholangitis, deregulation of histamine and bile-acid signaling may determine important changes in cellular pathways. The study of these molecular events may also shed some light on the pathogenesis of sporadic (unrelated to risk factors) forms of cholangiocarcinoma, which represent the majority (nearly 75%) of cases.
format Online
Article
Text
id pubmed-8945938
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89459382022-03-25 Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development Ceci, Ludovica Zhou, Tianhao Lenci, Ilaria Meadows, Vik Kennedy, Lindsey Li, Ping Ekser, Burcin Milana, Martina Zhang, Wenjun Wu, Chaodong Sato, Keisaku Chakraborty, Sanjukta Glaser, Shannon S. Francis, Heather Alpini, Gianfranco Baiocchi, Leonardo Cancers (Basel) Review SIMPLE SUMMARY: Cholangiocarcinoma is the second most frequent primary liver tumor in humans. In this review, we report current findings on the mechanisms linking well-known risk factors to this cancer. These pathways may be in part involved in risk factors unrelated to cholangiocarcinoma forms. ABSTRACT: The poor prognosis of cholangiocarcinoma in humans is related to several factors, such as (i) the heterogeneity of the disease, (ii) the late onset of symptoms and (iii) the limited comprehension of the carcinogenic pathways determining neoplastic changes, which all limit the pursuit of appropriate treatment. Several risk factors have been recognized, including different infective, immune-mediated, and dysmorphogenic disorders of the biliary tree. In this review, we report the details of possible mechanisms that lead a specific premalignant pathological condition to become cholangiocarcinoma. For instance, during liver fluke infection, factors secreted from the worms may play a major role in pathogenesis. In primary sclerosing cholangitis, deregulation of histamine and bile-acid signaling may determine important changes in cellular pathways. The study of these molecular events may also shed some light on the pathogenesis of sporadic (unrelated to risk factors) forms of cholangiocarcinoma, which represent the majority (nearly 75%) of cases. MDPI 2022-03-11 /pmc/articles/PMC8945938/ /pubmed/35326593 http://dx.doi.org/10.3390/cancers14061442 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ceci, Ludovica
Zhou, Tianhao
Lenci, Ilaria
Meadows, Vik
Kennedy, Lindsey
Li, Ping
Ekser, Burcin
Milana, Martina
Zhang, Wenjun
Wu, Chaodong
Sato, Keisaku
Chakraborty, Sanjukta
Glaser, Shannon S.
Francis, Heather
Alpini, Gianfranco
Baiocchi, Leonardo
Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
title Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
title_full Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
title_fullStr Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
title_full_unstemmed Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
title_short Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
title_sort molecular mechanisms linking risk factors to cholangiocarcinoma development
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945938/
https://www.ncbi.nlm.nih.gov/pubmed/35326593
http://dx.doi.org/10.3390/cancers14061442
work_keys_str_mv AT ceciludovica molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT zhoutianhao molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT lenciilaria molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT meadowsvik molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT kennedylindsey molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT liping molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT ekserburcin molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT milanamartina molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT zhangwenjun molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT wuchaodong molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT satokeisaku molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT chakrabortysanjukta molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT glasershannons molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT francisheather molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT alpinigianfranco molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment
AT baiocchileonardo molecularmechanismslinkingriskfactorstocholangiocarcinomadevelopment